Concepedia

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

Eric Lawitz, Mark Sulkowski, Ira M. Jacobson, Walter K. Kraft, Benedict Maliakkal, Mohamed Al‐Ibrahim, Stuart C. Gordon, Paul Y. Kwo, Juergen Rockstroh, Paul Panorchan,

Antiviral Research · 2013 · 33 citations · 12 references

DOI

Concepts

References

12

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Fred Poordad, Jonathan McCone, Bruce R. Bacon et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

, , +17

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text

, , +17

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

, , +14

Global surveillance and control of hepatitis C

Journal of Viral Hepatitis · 1999 · 903 citations

, , +14

Projecting future complications of chronic hepatitis C in the United States

Gary L. Davis · Liver Transplantation · 2003 · 579 citations · Full text

, , +14